elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
S12885-017-3641-6
S12885-017-3641-6
http://dx.doi.org/10.1186/S12885-017-3641-6
A phase I open-label dose-escalation study of the anti-HER3 monoclonal antibody LJM716 in patients with advanced squamous cell carcinoma of the esophagus or head and neck and HER2-overexpressing breast or gastric cancer.
P356
Q41173029-B7D4D00E-2E1A-4053-B702-297369E88541
P356
S12885-017-3641-6
http://dx.doi.org/10.1186/S12885-017-3641-6